Literature DB >> 3288959

Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment.

W G Mitchell1, T O Crawford.   

Abstract

Cerebral cysticercosis is being diagnosed with increasing frequency in children in the United States. A total of 52 patients with intraparenchymal cerebral cysticercosis, 21 months to 20 years of age, were observed for 2 to 72 months. Actively inflamed acute lesions, with or without coexisting chronic calcified lesions, were seen in 42 patients. Solitary lesions were seen in 39 patients, multiple lesions in 13. Chronic inactive calcified lesions were seen in ten children. A total of 51 patients had seizures that were either partial or partial with secondary generalization. Patients were treated with anticonvulsants. Praziquantel was not used. All active lesions resolved completely or with punctate calcification in 2 to 9 months, according to radiographic findings. Seizures were easily controlled. Patients were gradually weaned from anticonvulsants and in 60% no seizures recurred. Prognosis was generally good. Characteristics of the CT scans are detailed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288959

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  23 in total

1.  Cysticercosis.

Authors:  J F Bale
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

Review 2.  Neurocysticercosis--New Millennium, ancient disease and unending debate.

Authors:  G Narula; K S Bawa
Journal:  Indian J Pediatr       Date:  2003-04       Impact factor: 1.967

Review 3.  Controversies in the management of cysticercosis.

Authors:  C Evans; H H Garcia; R H Gilman; J S Friedland
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

Review 4.  Current status and future perspectives on the medical treatment of neurocysticercosis.

Authors:  Isidro Gonzales; Hector H Garcia
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 5.  Neurocysticercosis and epilepsy in developing countries.

Authors:  D K Pal; A Carpio; J W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

6.  A profile of childhood neurocysticercosis.

Authors:  V Kalra; M Suri; B L Jailkhani
Journal:  Indian J Pediatr       Date:  1994 Jan-Feb       Impact factor: 1.967

Review 7.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

Review 8.  Neurocysticercosis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

9.  Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments.

Authors:  Samuel Ong; David A Talan; Gregory J Moran; William Mower; Michael Newdow; Victor C W Tsang; Robert W Pinner
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

Review 10.  Management of neurocysticercosis.

Authors:  Terrence Riley; A C White
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.